Revitalist appoints Dr. Denise Hopkins-Chadwick as Senior Vice President of Research


Vancouver, British Columbia–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce the appointment of Dr. Denise Hopkins-Chadwick, PhD RN, retired Colonel of the U.S. Army as Vice President, Research (“R&D”).

Kathryn Walker, CEO, commented, “On behalf of the Revitalist team, I am very pleased to welcome Denise to the company. As Revitalist continues to grow, we are thrilled to have someone of Denise’s caliber and experience leading R&D in our organization. Denise will play a pivotal role in achieving our ambitious fundraising goals and securing grants to further Revitalist’s mission.

Denise Hopkins-Chadwick received her Ph.D. from The Ohio State University in Columbus, Ohio and has over 35 years of experience writing grants and working with patients, research participants, families and faculty. . Denise is a 30-year active duty veteran officer in the corps of nurses with clinical experience spanning adults in neonatal ICUs, emergency departments and patient transport. She sits on several boards, including the Military Medicine Journal and the Tri-Service Nursing Research Interest Group: Women’s Health. Throughout her career, she has received dozens of health care research awards and has secured over $50 million in research funding. She is the co-inventor of the Precision Health Insight tool, which integrates data from multiple sources, including behavioral health and pharmaceuticals, into a unified system. Denise is also the founder of HC Research Associates, a company providing professional R&D activities as well as academic activities.

Dr Denise Hopkins-Chadwick, commented, “I couldn’t be happier to join Revitalist and look forward to working with the team as we embark on the research and development of transformative programs that impact positive on patients and their families.


Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with clinics operating across the United States and growing. Revitalist is dedicated to empowering individuals toward a higher quality of well-being through a combination of comprehensive care and future-focused treatments provided by medical professionals, mental health experts and specialists in Chronic Pain. Since opening its first clinic in 2018, Revitalist has provided thousands of infusions to patients suffering from treatment-resistant diseases. Additionally, Revitalist offers a number of lifestyle enhancement services and vitamin infusions that can bring anyone one step closer to total wellness. For more information and to be added to the company’s mailing list, please click here.

On behalf of the board

Catherine Walker

Chief executive officer

Forward-looking statements

This press release contains forward-looking statements and information within the meaning of applicable securities laws. Often, but not always, forward-looking statements and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates”. , “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or states that certain actions, events or results “may”, “could”, “would”, “could” or “will” occur, occur or be realized. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause results, performance or achievements Revitalist’s actual results may differ materially from any future results, performance or achievements expressed or implied by any forward-looking statements or information contained in this press release.

The risks, uncertainties and other factors involved in forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and accepts no responsibility for the adequacy or accuracy of the content of this press release.


Comments are closed.